This 2015 meta-analysis reviewed data from three randomized controlled trials involving 294 patients to assess topiramate’s efficacy and safety in treating essential tremor (ET). The analysis showed that topiramate significantly improved tremor severity, motor function, and reduced functional disability compared to placebo. The mean difference in the Fahn–Tolosa–Marin Tremor Rating
